These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16308999)

  • 21. (TTA)n polymorphism in 3-hydroxy-3-methylglutaryl-coenzyme A and response to atorvastatin in coronary artery disease patients.
    Noriega V; Pennanen C; Sánchez MP; Chiong M; Llancaqueo M; Lavandero S; Prieto JC
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):211-5. PubMed ID: 19067673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of statins on collagen type I degradation in patients with coronary artery disease and atrial fibrillation.
    Tziakas DN; Chalikias GK; Stakos DA; Papanas N; Chatzikyriakou SV; Mitrousi K; Maltezos E; Boudoulas H
    Am J Cardiol; 2008 Jan; 101(2):199-202. PubMed ID: 18178406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of statin therapy on coronary intervention for non-ST elevation acute coronary syndrome with decreased low-density lipoprotein cholesterol.
    Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Shiba M; Wada M; Tsuji T; Komatsu H; Iijima R; Nakajima R; Yamamoto M; Yamamoto M; Yoshitama T; Takagi T; Hara H; Sugi K
    J Cardiol; 2007 Mar; 49(3):115-23. PubMed ID: 17444137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimizing statin drug therapy.
    Ramsey LA; Miles AJ
    Adv Nurse Pract; 2002 Mar; 10(3):27-8. PubMed ID: 12418333
    [No Abstract]   [Full Text] [Related]  

  • 25. Lipid-altering therapies and the progression of atherosclerotic disease.
    Wierzbicki AS
    Cardiovasc Intervent Radiol; 2007; 30(2):155-60. PubMed ID: 17206389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.
    Farnier M; Averna M; Missault L; Vaverkova H; Viigimaa M; Massaad R; Vandormael K; Johnson-Levonas AO; Brudi P
    Int J Clin Pract; 2009 Apr; 63(4):547-59. PubMed ID: 19222610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statins targeting inflammation by lowering low-density lipoprotein?
    Tuzcu EM; Nicholls SJ
    J Am Coll Cardiol; 2007 May; 49(20):2010-2. PubMed ID: 17512356
    [No Abstract]   [Full Text] [Related]  

  • 28. LDL-Cholesterol is the King.
    Goumas GS
    Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
    [No Abstract]   [Full Text] [Related]  

  • 29. Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.
    Teoh H; Mendelsohn AA; Goodman SG; Jaffer S; Chen RY; Tjia S; Theriault L; Langer A; Leiter LA;
    Am J Cardiol; 2009 Sep; 104(6):798-804. PubMed ID: 19733714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach.
    Aikawa M; Libby P
    Cardiovasc Pathol; 2004; 13(3):125-38. PubMed ID: 15081469
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials).
    Murphy SA; Cannon CP; Wiviott SD; de Lemos JA; Blazing MA; McCabe CH; Califf RM; Braunwald E
    Am J Cardiol; 2007 Oct; 100(7):1047-51. PubMed ID: 17884359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studying coronary plaque regression with IVUS: a critical review of recent studies.
    Carlier SG; Tanaka K
    J Interv Cardiol; 2006 Feb; 19(1):11-5. PubMed ID: 16483334
    [No Abstract]   [Full Text] [Related]  

  • 33. Med could reverse arterial blockages.
    Health News; 2006 Jul; 12(7):13. PubMed ID: 16858860
    [No Abstract]   [Full Text] [Related]  

  • 34. Safety and efficacy of achieving very low low-density lipoprotein cholesterol levels with rosuvastatin 40 mg daily (from the ASTEROID Study).
    Wiviott SD; Mohanavelu S; Raichlen JS; Cain VA; Nissen SE; Libby P
    Am J Cardiol; 2009 Jul; 104(1):29-35. PubMed ID: 19576317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statin use and prognosis in patients with advanced heart failure.
    Martínez-Sellés M; Domínguez M; Martínez E; García Fernández MA; García E
    Int J Cardiol; 2007 May; 118(1):135-7. PubMed ID: 16949689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurohumoral and inflammatory activation in patients with coronary artery disease treated with statins.
    Van de Veire NR; Philippé J; De Winter O; Langlois M; Bernard D; De Sutter J
    Heart; 2006 Dec; 92(12):1858-9. PubMed ID: 17105891
    [No Abstract]   [Full Text] [Related]  

  • 37. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of patients discharged from pharmacy-managed cardiovascular disease management.
    Olson KL; Delate T; Rasmussen J; Humphries TL; Merenich JA;
    Am J Manag Care; 2009 Aug; 15(8):497-503. PubMed ID: 19670953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statin use is associated with decreased CD-40 ligand expression on T lymphocytes of coronary atheroma plaque in patients with stable coronary artery disease.
    Türk U; Alioğlu E; Tengiz I; Ercan E; Mahmudov R; Duygu H; Türkoğlu C
    Anadolu Kardiyol Derg; 2008 Apr; 8(2):99-103. PubMed ID: 18400628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease.
    Chan PS; Nallamothu BK; Gurm HS; Hayward RA; Vijan S
    Circulation; 2007 May; 115(18):2398-409. PubMed ID: 17452609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.